Madrigal Pharmaceuticals (MDGL) Revenue & Revenue Breakdown
Madrigal Pharmaceuticals Revenue Highlights
0
Latest Revenue (Q)
$62.17M
Madrigal Pharmaceuticals Revenue by Period
Madrigal Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | -100.00% |
2012-12-31 | $147.00K | -98.06% |
2011-12-31 | $7.58M | -48.77% |
2010-12-31 | $14.80M | -89.74% |
2009-12-31 | $144.25M | 5416.06% |
2008-12-31 | $2.62M | 251.95% |
2007-12-31 | $743.00K | 100.00% |
2006-12-31 | - | 100.00% |
2005-12-31 | - | -100.00% |
2004-12-31 | $173.00K | -86.73% |
2003-12-31 | $1.30M | 100.00% |
2002-12-31 | - | 100.00% |
2001-12-31 | - | - |
Madrigal Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $62.17M | 324.75% |
2024-06-30 | $14.64M | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $770.00K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | -100.00% |
2012-03-31 | $147.00K | -95.71% |
2011-12-31 | $3.42M | 105.71% |
2011-09-30 | $1.66M | 22.90% |
2011-06-30 | $1.35M | 18.46% |
2011-03-31 | $1.14M | -71.69% |
2010-12-31 | $4.04M | 19.33% |
2010-09-30 | $3.38M | 0.68% |
2010-06-30 | $3.36M | -16.48% |
2010-03-31 | $4.02M | -14.04% |
2009-12-31 | $4.68M | -96.41% |
2009-09-30 | $130.41M | 2704.41% |
2009-06-30 | $4.65M | 3.10% |
2009-03-31 | $4.51M | 609.12% |
2008-12-31 | $636.00K | -50.00% |
2008-09-30 | $1.27M | -4.93% |
2008-06-30 | $1.34M | - |
2008-03-31 | $1.34M | 100.00% |
2007-12-31 | - | - |
Madrigal Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
SRPT | Sarepta Therapeutics | $1.24B | $362.93M |
PTCT | PTC Therapeutics | $937.82M | $135.42M |
TGTX | TG Therapeutics | $233.66M | $83.88M |
ACLX | Arcellx | $110.32M | $26.03M |
KRYS | Krystal Biotech | $50.70M | $83.84M |
MREO | Mereo BioPharma Group | $10.00M | - |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
PLRX | Pliant Therapeutics | $1.58M | - |
IOVA | Iovance Biotherapeutics | $1.19M | $58.55M |
XFOR | X4 Pharmaceuticals | - | $560.00K |
VKTX | Viking Therapeutics | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
MDGL | Madrigal Pharmaceuticals | - | $62.17M |
TERN | Terns Pharmaceuticals | - | - |
ETNB | 89bio | - | - |
HEPA | Hepion Pharmaceuticals | - | - |